[ARWR] YoY Quarter Result on 31-Mar-2023 [#Q2]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
02-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q2]
Profit Trend
QoQ- 216.42%
YoY- 9.71%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 146,267 151,805 32,811 23,529 48,148 650 -
PBT -126,996 47,676 44,366 -26,818 -19,836 23,897 -14,884 42.90%
Tax -1,696 -999 -2,813 -1,524 0 -0 -150 49.75%
NP -125,300 48,675 44,366 -26,818 -19,836 23,897 -14,884 42.58%
Tax Rate - 2.10% 6.34% - - 0.00% - -
Total Cost 125,300 97,592 107,439 59,629 43,364 24,251 15,534 41.57%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 33.28 29.23 -81.73 -84.30 49.63 -2,289.45 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -1.02 0.46 0.42 -0.26 -0.20 0.25 -0.18 33.48%
EPS Diluted -1.02 0.45 0.41 -0.26 -0.20 0.24 -0.18 33.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.